1. Khlopkov, A., Pomper, M., and Chekina, V., Cessation of using highly enriched uranium in production of medical isotopes: possibilities of cooperation of Russia and the United States, Report of the Center for Energy and Security Studies, www.ceness-russia.org (addressed Nov. 28, 2017).
2. Rosatom nameren stat’ mirovym liderom proizvodstva molibdena-99 (Rosatom Intends to Become a World Leader in Molybdenum-99 Production), https://ria.ru/atomtec/20160330/1399733135.html (addressed Nov. 28, 2017).
3. V tsentre mezhdunarodnogo vnimaniya (In the Center of International Attention), http://www.strana-rosatom.ru (addressed Nov. 28, 2017).
4. Homogeneous aqueous solution nuclear reactors for the production of Mo-99 and other short-lived radioisotopes, IAEA-TECDOC-1601, Vienna: IAEA, 2008.
5. Pavshuk, V.A. and Chuvilin, D.Yu., Production of nuclear fuel fission radionuclides, Izotopy: svoistva, poluchenie, primenenie (Isotopes: Properties, Production, and Use), Baranov, V.Yu., Ed., Moscow: Fizmatlit, 2005, vol.1.